Study guide
Cardiac Complications of Brain Injury
ABPN Neurocritical Care Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU
Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU
2 Chapter 2: Cerebral Physiology & Intracranial Dynamics
Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes
3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management
Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions
4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management
Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy
5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management
Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury
6 Chapter 6: Neuropharmacology, Analgesia & Sedation
ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU
7 Bleeding, Thrombosis & Hematologic Emergencies
Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity
8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine
Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention
9 Systemic Trauma & Environmental Injury
Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging
10 Cardiac Emergencies & Mechanical Support
IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies
11 Kidney Injury, Acid–Base & Renal Replacement
Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement
12 Systemic Infection & Endocrine Emergencies
Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies
13 Gastrointestinal & Hepatic Emergencies
Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects
14 Chapter 9: Neuroimaging in the Neuro-ICU
Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness
15 Chapter 10: Electrophysiology & Neuromonitoring
Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler
16 Angiography, Electrodiagnosis & CSF Analysis
Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage
17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria
Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria
18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies
Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction
19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage
Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH
20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia
Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations
21 Venous, Spinal & Traumatic Vascular Disease
Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury
22 Chapter 15: Traumatic Brain & Spinal Cord Injury
Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes
23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies
Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure
24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis
Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies
25 Neuroinflammation & Neurooncology
Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies
26 Pregnancy, Transplantation & Pediatric Care
Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care
27 Chapter 18: Neurosurgical & Perioperative Emergencies
Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies
28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU
Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor
Cardiac Complications of Brain Injury
Key Takeaways Explain This Topic AI
Acute catastrophic brain injury (particularly aneurysmal subarachnoid hemorrhage, severe traumatic brain injury, and insular stroke) triggers a massive sympathetic surge with excessive local cardiac norepinephrine exocytosis, resulting in myocyte calcium overload, contraction band necrosis, and transient neurogenic stunned myocardium ( N S M NSM NSM ).
Neurogenic stunned myocardium and Takotsubo cardiomyopathy classically present with acute regional wall motion abnormalities that extend beyond a single epicardial coronary artery distribution, accompanied by disproportionately modest troponin elevations compared to the severity of ventricular dysfunction.
In classic apical Takotsubo cardiomyopathy, compensatory basal hyperkinesis combined with apical akinesis can induce systolic anterior motion ( S A M SAM S A M ) of the mitral valve and dynamic left ventricular outflow tract ( L V O T LVOT L V OT ) obstruction; in this setting, standard inotropes (dobutamine, milrinone, epinephrine) are strictly contraindicated because they worsen the subaortic gradient.
Hemodynamic management of dynamic L V O T LVOT L V OT obstruction requires volume expansion, afterload augmentation with pure α 1 \alpha_1 α 1 agonists (phenylephrine), and cautious β \beta β -blockade to reduce heart rate and basal hypercontractility.
Common electrocardiographic manifestations of intracranial hypertension and sympathetic storming include massive, deep symmetric "cerebral T waves", marked QTc prolongation predisposing to torsades de pointes, and Cushing's reflex-mediated sinus bradycardia.
Last updated: October 2026
Cardiac Complications of Brain Injury
Acute brain injury frequently precipitates profound, life-threatening cardiovascular dysfunction. The physiological coupling between the central nervous system and the heart—termed the brain-heart axis —mediates a spectrum of disorders ranging from benign electrocardiographic repolarization abnormalities to neurogenic stunned myocardium, malignant ventricular arrhythmias, and cardiogenic shock. Clinicians in the neuro-ICU must rapidly distinguish neurogenic cardiac injury from primary acute coronary syndromes ( A C S ACS A CS ) and tailor resuscitation to avoid fatal hemodynamic missteps.
The Brain-Heart Connection and the Sympathetic Surge
The central autonomic network ( C A N CAN C A N ) regulates cardiac chronotropy, inotropy, and vascular tone. Key anatomic nodes include:
Insular Cortex: The primary cortical coordinator of autonomic outflow. The right insula predominantly modulates cardiac sympathetic outflow; lesions here (e.g., acute right MCA or insular ischemic stroke) disinhibit sympathetic activity, triggering severe tachyarrhythmias and hypertension. The left insula modulates parasympathetic tone.
Hypothalamus: Integrates visceral autonomic responses via the paraventricular and dorsomedial nuclei.
Rostral Ventrolateral Medulla (RVLM): The primary brainstem center generating basal and reflex sympathetic vasomotor tone.
When acute intracranial catastrophes occur—most classically aneurysmal subarachnoid hemorrhage ( a S A H aSAH a S A H ), severe traumatic brain injury ( T B I TBI TB I ), or sudden intracranial hypertension—the central autonomic network unleashes a massive, uncontrolled sympathetic discharge. Rather than circulating adrenal epinephrine, it is the excessive, toxic exocytosis of norepinephrine directly from cardiac sympathetic nerve endings terminating on ventricular myocytes that drives neurogenic myocardial damage.
This local catecholamine deluge triggers:
Intracellular Calcium Hyper-Accumulation: Exhausts sarco/endoplasmic reticulum Ca 2 + \text{Ca}^{2+} Ca 2 + -ATPase ( S E R C A SERCA SERC A ) pumps, inducing sustained actin-myosin cross-linking and hypercontraction.
Contraction Band Necrosis: Dense, hypercontracted sarcomeres with disrupted Z-discs and myocyte calcification, pathognomonic of catecholamine toxicity and clearly distinct from the coagulation necrosis of ischemic infarction.
Coronary Microvascular Vasospasm & Metabolic Exhaustion: Spasm of intramural microvessels combined with extreme myocardial oxygen demand leads to profound, transient myocardial stunning.
Neurogenic Stunned Myocardium (NSM) and Takotsubo Cardiomyopathy
Neurogenic stunned myocardium ( N S M NSM NSM ) and stress-induced (Takotsubo) cardiomyopathy represent clinical phenotypes of this catecholaminergic myocardial injury. NSM occurs in 20 – 30 % 20\text{--}30\% 20 – 30% of patients with high-grade (Hunt-Hess IV–V) aneurysmal subarachnoid hemorrhage and carries high risks of pulmonary edema and delayed cerebral ischemia.
Phenotypic Variants of Takotsubo Cardiomyopathy
Phenotype Echocardiographic Features Anatomical Distribution of Wall Motion Abnormality Clinical Frequency & Setting
Classic (Apical) Takotsubo Apical and mid-ventricular ballooning (akinesis/dyskinesis) with basal hyperkinesis Circumferential apical segments extending beyond any single coronary artery territory Most common in post-menopausal women following emotional/physical shock; common in aSAH
Inverted (Basal) Takotsubo Basal and mid-ventricular akinesis/hypokinesis with preserved or hyperdynamic apical contraction Basal circumferential segments Disproportionately frequent in younger patients with acute catastrophic neurological injury (aSAH, severe TBI)
Mid-Ventricular Takotsubo Mid-ventricular hypokinesis with apical and basal sparing Mid-cavity ventricular ring Less common; observed in status epilepticus and ischemic stroke
Global Hypokinesis Diffuse, symmetric biventricular depression Global myocardium without regional sparing Severe intracranial hypertension, brain death progression
Diagnostic Differentiation: NSM / Takotsubo vs. Acute Coronary Syndrome (ACS)
Differentiating neurogenic stunning from an acute ST-elevation or non-ST-elevation myocardial infarction ( S T E M I STEMI STEM I / N S T E M I NSTEMI NSTEM I ) is critical in the acute neuro-ICU setting:
Parameter Neurogenic Stunned Myocardium (NSM / Takotsubo) Acute Myocardial Infarction (ACS / Plaque Rupture)
Wall Motion Abnormalities Non-coronary distribution (circumferential apical or basal involvement crossing multiple vascular territories) Coronary distribution (conforms strictly to a single epicardial vascular territory: LAD, LCx, or RCA)
Cardiac Biomarkers (Troponin) Disproportionately modest troponin elevation relative to the profound extent of wall motion impairment and cardiogenic shock Substantial troponin elevation that correlates proportionally with the size of the ischemic territory
Natriuretic Peptides (BNP/NT-proBNP) Markedly elevated (often > 1 , 000 – 5 , 000 pg/mL > 1,000\text{--}5,000\text{ pg/mL} > 1 , 000 – 5 , 000 pg/mL ) due to acute ventricular stretch Moderately elevated unless accompanied by chronic heart failure
Coronary Angiography (Invasive or CTA) Absence of acute obstructive culprit lesion, plaque rupture, or acute thrombus Presence of acute culprit coronary occlusion or unstable plaque
Ventricular Recovery Fully reversible ; wall motion abnormalities typically resolve within 1 to 4 weeks Persistent regional akinesis and chronic myocardial scarring
Dynamic Left Ventricular Outflow Tract (LVOT) Obstruction: The Critical Pitfall
In classic apical Takotsubo cardiomyopathy, the apical two-thirds of the ventricle is akinetic while the basal segments are compensatory and severely hyperdynamic. This hyperdynamic basal contraction, combined with altered ventricular geometry, creates high-velocity blood flow through the narrow subaortic vestibule.
By the Venturi effect , this high-velocity jet draws the anterior leaflet of the mitral valve toward the ventricular septum during systole—a phenomenon termed Systolic Anterior Motion ( S A M SAM S A M ) of the mitral valve .
This interaction results in:
Dynamic Subaortic Stenosis: Severe obstruction to forward blood flow, dropping cardiac output and triggering refractory cardiogenic shock.
Acute Mitral Regurgitation: Malcoaptation of the anterior mitral leaflet produces severe, posteriorly directed mitral regurgitation and flash pulmonary edema.
Warning
Inotropes are Strictly Contraindicated in Dynamic LVOT Obstruction:
Administering inotropic agents (dobutamine, milrinone, dopamine, or epinephrine) in a patient with Takotsubo cardiomyopathy and dynamic L V O T LVOT L V OT obstruction exacerbates basal hyperkinesis , increases the subaortic gradient, worsens mitral regurgitation, and precipitates cardiovascular collapse.
Bedside Management of Dynamic LVOT Obstruction:
Stop all inodilators and inotropes immediately.
Volume Resuscitation: Administer judicious fluid boluses to increase end-diastolic volume, widening the L V LV L V outflow tract.
Augment Afterload: Use phenylephrine (pure α 1 \alpha_1 α 1 agonist). Elevating systemic vascular resistance increases afterload, expanding the L V LV L V chamber diameter and reducing the pressure gradient.
Cautious β \beta β -Blockade: Administer short-acting β \beta β -blockers (e.g., intravenous esmolol) to reduce basal hyperkinesis and prolong diastolic filling time, eliminating S A M SAM S A M .
Temporary ventricular support: Selection depends on anatomy, ventricular function, outflow obstruction, preload, and procedural expertise. Microaxial support has been used in selected Takotsubo shock cases; do not teach dynamic LVOT obstruction as a universal absolute device contraindication.
Electrocardiographic Abnormalities in Neurocritical Care
Acute brain injury produces striking, protean electrocardiographic derangements in up to 60 – 90 % 60\text{--}90\% 60 – 90% of patients with subarachnoid hemorrhage and traumatic brain injury.
ECG Abnormality Morphological Features Underlying Neurogenic Mechanism Clinical Significance & Management
"Cerebral T Waves" Giant, deep, symmetric, inverted T waves (often > 5 – 10 mm > 5\text{--}10\text{ mm} > 5 – 10 mm amplitude) across precordial leads ( V 1 – V 6 V_1\text{--}V_6 V 1 – V 6 ) Massive, heterogeneous myocardial repolarization delay driven by asymmetric sympathetic outflow Frequently misidentified as acute anterior S T E M I STEMI STEM I or Wellens syndrome; typically resolves as I C P ICP I CP normalizes
QTc Prolongation Bazett-corrected Q T c > 480 – 500 ms QTc > 480\text{--}500\text{ ms} QT c > 480 – 500 ms Altered ventricular recovery time from excessive catecholamine exposure High risk of polymorphic ventricular tachycardia ( Torsades de Pointes ); maintain K + ≥ 4.0 mEq/L \text{K}^+ \ge 4.0\text{ mEq/L} K + ≥ 4.0 mEq/L , Mg 2 + ≥ 2.0 mg/dL \text{Mg}^{2+} \ge 2.0\text{ mg/dL} Mg 2 + ≥ 2.0 mg/dL ; avoid QT-prolonging drugs
ST-Segment Elevation / Depression ST elevation in precordial leads or diffuse subendocardial ST depression Microvascular coronary vasospasm or subendocardial ischemia from contraction band necrosis Mimics acute coronary occlusion; requires urgent bedside echocardiography to assess wall motion distribution
Prominent U Waves Positive deflection following the T wave, often fusing with repolarization Delayed repolarization of Mid-myocardial M-cells and Purkinje fibers Exacerbates apparent QT prolongation; monitor electrolytes closely
Sinus Bradycardia Heart rate < 60 bpm < 60\text{ bpm} < 60 bpm (often < 40 bpm < 40\text{ bpm} < 40 bpm ) Cushing's Response: Intracranial hypertension compresses the lower brainstem, triggering medullary ischemia and vagal hyperactivation Ominous sign of impending brain herniation; requires emergent osmotic therapy and hyperventilation rather than atropine
Supraventricular Arrhythmias Atrial fibrillation, atrial flutter, multifocal atrial tachycardia Atrial stretch, elevated pulmonary pressures, and adrenergic storming Rate control with cautious β \beta β -blockers or calcium channel blockers; avoid worsening hypotension
Ventricular Arrhythmias Premature ventricular contractions ( P V C s PVCs P V C s ), non-sustained V T VT V T , sustained V T VT V T , or ventricular fibrillation Enhanced myocyte automaticity, triggered activity, and re-entry in damaged myocardium Immediate defibrillation for pulseless V T / V F VT/VF V T / V F ; magnesium sulfate for Torsades de Pointes; antiarrhythmics (lidocaine, amiodarone)
Important
The Cushing Response (hypertension, bradycardia, and irregular respirations) reflects severe brainstem compression and distortion of the rostral ventrolateral medulla and vagal nuclei. The bradycardia of Cushing's reflex is a central vagal response to life-threatening intracranial pressure. Treating this bradycardia with cardiac pacing or atropine without addressing the underlying intracranial hypertension will result in fatal brain herniation.